Popular
A Multidisciplinary Approach to Treating Itch
Dermatology Hub: Neuroimmune NetworkA Multidisciplinary Approach to Treating Itch
J. Mark Jackson, MD
The Treatment Planning Process for Atopic Dermatitis
Dermatology Hub: Neuroimmune NetworkThe Treatment Planning Process for Atopic Dermatitis
Brad Glick, DO, MPH
Mechanism of Action for Aryl Hydrocarbon Receptor Agonists
Practical DermatologyMechanism of Action for Aryl Hydrocarbon Receptor Agonists
Neal Bhatia, MD, FAAD
Joshua Grosshandler, MD, FAAD
Skin Barrier Maintenance in Atopic Dermatitis and Psoriasis
Practical DermatologySkin Barrier Maintenance in Atopic Dermatitis and Psoriasis
Neal Bhatia, MD, FAAD
Joshua Grosshandler, MD, FAAD
Potential Impact of Aryl Hydrocarbon Activation on Pigment
Practical DermatologyPotential Impact of Aryl Hydrocarbon Activation on Pigment
Neal Bhatia, MD, FAAD
Joshua Grosshandler, MD, FAAD
Programs
A Multidisciplinary Approach to Treating Itch
Dermatology Hub: Neuroimmune NetworkA Multidisciplinary Approach to Treating Itch
J. Mark Jackson, MD
Antihistamine Selection and Measuring Disease Control in Chronic Spontaneous Urticaria
Practical DermatologyAntihistamine Selection and Measuring Disease Control in Chronic Spontaneous Urticaria
Michelle B. Tarbox, MD
Naiem T. Issa, MD, PhD, FAAD
Maureen N. Offiah, MD, FAAD
Beyond Skin Clearance: What Patient-Reported Outcomes Reveal in Atopic Dermatitis
Practical Dermatology: Updates in Atopic DermatitisBeyond Skin Clearance: What Patient-Reported Outcomes Reveal in Atopic Dermatitis
G. Michael Lewitt, MD
Treatment Challenges with Chronic Atopic Dermatitis
Practical DermatologyTreatment Challenges with Chronic Atopic Dermatitis
Naiem T. Issa, MD, PhD, FAAD
Maureen N. Offiah, MD, FAAD
Clinical Practice
Continuous Glucose and Ketone Monitoring: Making Smarter Decisions in Diabetes
CME/CEContinuous Glucose and Ketone Monitoring: Making Smarter Decisions in Diabetes
Stephen Brunton, MD, FAAFP, CDCES
James R. Gavin III, MD, PhD
Davida F. Kruger, MSN, APN-BC, BC-ADM
Eden Miller, DO, D-ACD, D-ABOM
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
CME/CEEngineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
Sticking Points: Managing Injection Site Reactions From Long-Acting Injectable Medications for HIV Care
CME/CESticking Points: Managing Injection Site Reactions From Long-Acting Injectable Medications for HIV Care
Dakota Price, MD
Emma Atkinson, PharmD
Navigating Severe Asthma Together: A Patient-Clinician Conversation
Deep Breaths: Updates from CHESTNavigating Severe Asthma Together: A Patient-Clinician Conversation
Diego Maselli, MD, FCCP
Individualizing Management Strategies for PSVT: Incorporating Patient Preference
MinuteCE®Individualizing Management Strategies for PSVT: Incorporating Patient Preference
Jennifer Carlquist, PA-C
Sean Pokorney, MD, MBA
Brian P. Rose, PA-C, MPH
- CME/CE In-Person & Virtual Event
Spotlight on B7-H3 ES-SCLC: Applying ADC Evidence in Real-World Practice
December 5, 2026
Scottsdale, Arizona
Doctors Lounge
Beyond AI Scribes: Rethinking the Outpatient Clinical Encounter
The ConvergenceBeyond AI Scribes: Rethinking the Outpatient Clinical Encounter
Inderbir S. Gill, MD
Brian P. McDonough, MD, FAAFP
Humanoids in Healthcare: Extending the Reach of Surgical Expertise
The ConvergenceHumanoids in Healthcare: Extending the Reach of Surgical Expertise
Brian P. McDonough, MD, FAAFP
Michael Yip, PhD
AI in Point-of-Care Ultrasound: Balancing Innovation With Clinical Judgment
Clinician's RoundtableAI in Point-of-Care Ultrasound: Balancing Innovation With Clinical Judgment
Taro Minami, MD, FCCP
Brian P. McDonough, MD, FAAFP
Michael Moor, MD, PhD
Collaboration in Medical Affairs: Increasing Value and Impact
MAPSChatsCollaboration in Medical Affairs: Increasing Value and Impact
Matt Birnholz, MD
Renu Juneja, PhD
Turning Insight into Action: The Expanding Role of Medical Affairs
MAPSChatsTurning Insight into Action: The Expanding Role of Medical Affairs
Matt Birnholz, MD
Michael DeLuca, PharmD, MBA, MSRA
CME
Translating Evidence Into Practice: Myosin Inhibition Across the HCM Spectrum
CME/CETranslating Evidence Into Practice: Myosin Inhibition Across the HCM Spectrum
Christian Schulze, MD, PhD
Ahmad Masri, MD, MS
Michelle Michels, MD
- CME/CE In-Person & Virtual Event
22nd Annual Women’s Health Annual Visit (WHAV)
November 13, 2026
Pasadena, California Recurrence as the Rule: BD Symptoms Persist and Cycle
MinuteCE®Recurrence as the Rule: BD Symptoms Persist and Cycle
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
The Unmet Need in ASCVD: Why Targets Are Still Not Enough
MinuteCE®The Unmet Need in ASCVD: Why Targets Are Still Not Enough
Erin Michos
Non-Obstructive HCM in Focus: Symptoms, Quality of Life, and Unmet Therapeutic Need
CME/CENon-Obstructive HCM in Focus: Symptoms, Quality of Life, and Unmet Therapeutic Need
Ahmad Masri, MD, MS
Michelle Michels, MD, PhD
Secondary Stroke Prevention in Focus: Addressing Residual Thrombotic Risk
CME/CE Broadcast ReplaySecondary Stroke Prevention in Focus: Addressing Residual Thrombotic Risk
Deborah Kerrigan, MD
Clay Johnston, MD
Industry Feature
Single-Port Robotics Improves Outcomes for Thoracic Surgery
Medical Industry FeatureSingle-Port Robotics Improves Outcomes for Thoracic Surgery
Benjamin Lee, M.D.
Jeffrey Port, M.D.
Jonathan Villena-Vargas, M.D.
Advancing Care in Pediatric Atopic Dermatitis
DermConsultAdvancing Care in Pediatric Atopic Dermatitis
Jennifer Caudle, DO, FACOFP
Nicole Chase, MD
Fred Ghali, MD, FAAD
Treatment Considerations in Ulcerative Colitis: Shared Decision-Making
Medical Industry FeatureTreatment Considerations in Ulcerative Colitis: Shared Decision-Making
David T. Rubin, MD
Josh Steinberg, MD
Taking Action in Friedreich Ataxia From Diagnosis to Treatment
Medical Industry FeatureTaking Action in Friedreich Ataxia From Diagnosis to Treatment
Jennifer Caudle, DO, FACOFP
David Lynch, MD
Laura Bleekrode, MD
Quick Takes in ATTR-CM: Diagnosis Barriers
Medical Industry FeatureQuick Takes in ATTR-CM: Diagnosis Barriers
Ola Akinboboye, MD, MBH, MBA
Applying a “Do No Harm” Mindset to Moderate-to-Severe Plaque Psoriasis Treatment Selection
Medical Industry FeatureApplying a “Do No Harm” Mindset to Moderate-to-Severe Plaque Psoriasis Treatment Selection
Charles Turck, PharmD, BCPS, BCCCP
Sam Awan, MD
Tina Bhutani, MD, MAS